Laboratory of Reproductive Biology, Scientific Unit & Fertility Clinic, Horsens-Braedstrup Hospital, Horsens, Denmark.
Syst Biol Reprod Med. 2011 Jun;57(3):154-61. doi: 10.3109/19396368.2010.550796. Epub 2011 Feb 2.
Testicular volume, hormones, and growth factors are used as predictors of finding motile testicular sperm in azoospermic men. In this study, the possible predictive value of very simple parameters such as systematic history, clinical examination, and determination of ejaculate volume have been evaluated. Two-hundred and sixty-two consecutive non-vasectomized men with azoospermia/aspermia were evaluated by systematic history, clinical examination, ultrasonography of the scrotal content, and hormonal and genetic analyses. Hormonal analyses included, as a minimum, determination of follicular stimulating hormone (FSH), luteinizing hormone (LH), and testosterone, while genetic analyses included karyotyping and examination for cystic fibrosis transmembrane conductance regulator (CFTR) mutations and Y microdeletions. In seventy-six cases (29%) genetics was the most likely cause of azoospermia. For men with at least one CFTR mutation, motile sperm could be detected in 100% of 13 men with congenital bilateral absence of vasa deferentia (VD) but only in 44% of 18 with present VD. Ejaculate volumes were significantly lower (2.3 mL versus 3.6 mL) in 81 men with motile testicular sperm detected compared to 111 men without detectable motile sperm (p < 0.001; Student's t-test), and the difference was still significant after exclusion of men carrying a CFTR mutation. Based on the present data, an ejaculate volume of 2.5 mL was considered a useful threshold value. Furthermore, an inhomogeneous histological pattern with maturation of sperm in small islands isolated in tissue showing Sertoli cell only (SCO) pattern seems characteristic for men with a history of cryptorchidism (negative predictive value: 95%). In addition to FSH, testicular volume, and other endocrine factors, it is important to consider that very simple factors such as ejaculate volume and presence or absence of VD in men with CFTR mutations might be used as predictors according to the chance of finding motile testicular sperm. Evidence for a strong association between a history of cryptorchidism and an inhomogeneous histological pattern with maturation of sperm in islands in tissue presenting SCO pattern might indicate that multiple TESEs should be considered in men with a history of cryptorchidism.
睾丸体积、激素和生长因子被用作预测无精子症男性中可游动睾丸精子的指标。在这项研究中,评估了系统病史、临床检查和精液量测定等非常简单参数的可能预测价值。对 262 名连续的非输精管结扎术无精子症/少精子症男性进行了系统病史、临床检查、阴囊内容物超声检查以及激素和遗传分析。激素分析至少包括卵泡刺激素(FSH)、黄体生成素(LH)和睾酮的测定,而遗传分析包括核型分析和囊性纤维化跨膜电导调节因子(CFTR)突变和 Y 微缺失的检查。在 76 例(29%)中,遗传因素是无精子症最可能的原因。对于至少有一种 CFTR 突变的男性,在 13 例先天性双侧输精管缺如(VA)的男性中可以检测到可游动精子,而在 18 例存在 VA 的男性中仅检测到 44%。与 111 名未检测到可游动精子的男性相比,在检测到可游动睾丸精子的 81 名男性中,精液量明显更低(2.3 毫升对 3.6 毫升)(p<0.001;学生 t 检验),而且在排除携带 CFTR 突变的男性后,这种差异仍然显著。基于目前的数据,2.5 毫升的精液量被认为是一个有用的阈值。此外,具有精子在仅显示支持细胞的小岛中成熟的不均匀组织学模式(SCO 模式)的历史似乎是隐睾症(阴性预测值:95%)男性的特征。除了 FSH、睾丸体积和其他内分泌因素外,重要的是要考虑到在携带 CFTR 突变的男性中,非常简单的因素,如精液量和 VA 的存在与否,可能会根据发现可游动睾丸精子的机会被用作预测指标。隐睾症病史和精子在组织中以 SCO 模式成熟的小岛中成熟的不均匀组织学模式之间存在强烈关联的证据可能表明,对于隐睾症病史的男性,应该考虑多次睾丸精子抽吸术。